Biogen to buy the retinal gene therapy maker Nightstar
Monday, May 27, 2019 - 21:07
in Mathematics & Economics
The $800 million purchase is the third gene therapy acquisition announced in a week
Updated by artificial intelligence Mon, 21 Jul 2025, 12:58:56 UTC Learn more
- Tell your friends
- Get science news via